FR2160407A1 - - Google Patents
Info
- Publication number
- FR2160407A1 FR2160407A1 FR7239498A FR7239498A FR2160407A1 FR 2160407 A1 FR2160407 A1 FR 2160407A1 FR 7239498 A FR7239498 A FR 7239498A FR 7239498 A FR7239498 A FR 7239498A FR 2160407 A1 FR2160407 A1 FR 2160407A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5375071A GB1400999A (en) | 1971-11-19 | 1971-11-19 | Imidazo-triazine compounds and their use in therapeutic compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2160407A1 true FR2160407A1 (en) | 1973-06-29 |
FR2160407B1 FR2160407B1 (en) | 1975-10-17 |
Family
ID=10468856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7239498A Expired FR2160407B1 (en) | 1971-11-19 | 1972-11-08 |
Country Status (18)
Country | Link |
---|---|
US (1) | US3840537A (en) |
JP (1) | JPS563873B2 (en) |
AT (1) | AT321923B (en) |
AU (1) | AU472127B2 (en) |
BE (1) | BE791025A (en) |
CA (1) | CA990292A (en) |
CH (1) | CH594671A5 (en) |
DE (1) | DE2255172A1 (en) |
DK (1) | DK138691B (en) |
ES (1) | ES408736A1 (en) |
FR (1) | FR2160407B1 (en) |
GB (1) | GB1400999A (en) |
IE (1) | IE37046B1 (en) |
IL (1) | IL40686A (en) |
NL (1) | NL7215646A (en) |
PH (1) | PH9669A (en) |
SE (1) | SE402915B (en) |
ZA (1) | ZA727532B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2213058A1 (en) * | 1973-01-04 | 1974-08-02 | Allen & Hanburys Ltd | |
FR2384773A1 (en) * | 1977-03-25 | 1978-10-20 | Allen & Hanburys Ltd | NEW HETEROCYCLIC COMPOUNDS WITH SPASMOLYTIC ACTIVITY |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2314488C3 (en) * | 1973-03-23 | 1979-01-04 | C.H. Boehringer Sohn, 6507 Ingelheim | 8- (2,6-Dichlorophenyl) -7- (4-chlorophenyl) -5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazine, process for its preparation and medicament containing it |
DE2335193A1 (en) * | 1973-07-11 | 1975-01-30 | Hoechst Ag | BIS-TRIAZINOBENZIMIDAZOLE AND THEIR PRODUCTION |
US4107307A (en) * | 1977-02-03 | 1978-08-15 | American Cyanamid Company | Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones |
US4115572A (en) * | 1977-02-03 | 1978-09-19 | American Cyanamid Company | Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma |
USRE30511E (en) * | 1977-02-03 | 1981-02-10 | American Cyanamid Company | Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones |
US4107308A (en) * | 1977-10-18 | 1978-08-15 | American Cyanamid Company | Imidazo[1,5-d]-as-triazines |
US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
HU187474B (en) * | 1981-11-18 | 1986-01-28 | Gyogyszerkutato Intezet,Hu | Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives |
US4395547A (en) * | 1982-02-10 | 1983-07-26 | American Cyanamid Co. | Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones |
AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
ATE213246T1 (en) * | 1997-11-12 | 2002-02-15 | 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS | |
DE19827640A1 (en) * | 1998-06-20 | 1999-12-23 | Bayer Ag | New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction |
IL141335A0 (en) | 1998-08-26 | 2002-03-10 | Smithkline Beecham Corp | Therapies for treating pulmonary diseases |
EA006685B1 (en) | 1999-08-21 | 2006-02-24 | Алтана Фарма Аг | Synergistic combination |
DK1392314T3 (en) * | 2001-05-09 | 2007-03-12 | Bayer Healthcare Ag | Hitherto unknown use of 2- [2-ethoxy-5- (4-methyl-piperazine-1-sulfonyl) -phenyl] -5-methyl-7-propyl-3H-imidazo [5,1-f] [1,2 , 4] triazin-4-one |
GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
DE10135815A1 (en) | 2001-07-23 | 2003-02-06 | Bayer Ag | Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain |
DE10232113A1 (en) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Medicinal products containing vardenafil hydrochloride trihydrate |
ES2326808T3 (en) * | 2003-04-01 | 2009-10-20 | Smithkline Beecham Corporation | IMIDAZOTRIAZINE COMPOUNDS FOR THE TREATMENT OF CANCER DISEASES. |
EP2168968B1 (en) | 2004-04-02 | 2017-08-23 | OSI Pharmaceuticals, LLC | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
DE102005001989A1 (en) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenous formulations of PDE inhibitors |
DE102005009240A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with improved pharmacokinetic properties |
DE102005009241A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with controlled bioavailability |
BRPI0616633A2 (en) * | 2005-09-29 | 2011-06-28 | Bayer Healthcare Ag | pde inhibitors and combinations thereof for the treatment of urological disorders |
EP1951724B1 (en) * | 2005-11-17 | 2011-04-27 | OSI Pharmaceuticals, Inc. | FUSED BICYCLIC mTOR INHIBITORS |
KR20100029762A (en) * | 2007-06-13 | 2010-03-17 | 바이엘 쉐링 파마 악티엔게젤샤프트 | Pde inhibitors for the treatment of hearing impairment |
CN102405214A (en) | 2009-04-20 | 2012-04-04 | Osi药物有限责任公司 | Preparation of c-pyrazine-methylamines |
CN103374002B (en) * | 2012-04-19 | 2015-07-15 | 山东轩竹医药科技有限公司 | Phosphodiesterase-5 inhibitor |
US20180044343A1 (en) * | 2015-03-16 | 2018-02-15 | Sumitomo Dainippon Pharma Co., Ltd. | Bicyclic imidazolo derivative |
WO2017000276A1 (en) * | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic compounds as pde2 inhibitors |
WO2017204316A1 (en) * | 2016-05-27 | 2017-11-30 | 塩野義製薬株式会社 | 5-oxo-1,2,4-triazine derivative, and pharmaceutical composition thereof |
-
0
- BE BE791025D patent/BE791025A/en unknown
-
1971
- 1971-11-19 GB GB5375071A patent/GB1400999A/en not_active Expired
-
1972
- 1972-10-23 ZA ZA727532A patent/ZA727532B/en unknown
- 1972-10-23 IE IE1433/72A patent/IE37046B1/en unknown
- 1972-10-23 DK DK525172AA patent/DK138691B/en unknown
- 1972-10-25 US US00300749A patent/US3840537A/en not_active Expired - Lifetime
- 1972-10-26 AU AU48191/72A patent/AU472127B2/en not_active Expired
- 1972-10-27 IL IL40686A patent/IL40686A/en unknown
- 1972-11-01 CA CA155,720A patent/CA990292A/en not_active Expired
- 1972-11-06 SE SE7214358A patent/SE402915B/en unknown
- 1972-11-08 FR FR7239498A patent/FR2160407B1/fr not_active Expired
- 1972-11-10 DE DE2255172A patent/DE2255172A1/en not_active Withdrawn
- 1972-11-16 PH PH14090*UA patent/PH9669A/en unknown
- 1972-11-16 CH CH1668372A patent/CH594671A5/xx not_active IP Right Cessation
- 1972-11-17 NL NL7215646A patent/NL7215646A/xx not_active Application Discontinuation
- 1972-11-17 JP JP11549572A patent/JPS563873B2/ja not_active Expired
- 1972-11-17 ES ES408736A patent/ES408736A1/en not_active Expired
- 1972-11-17 AT AT982372A patent/AT321923B/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
NEANT * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2213058A1 (en) * | 1973-01-04 | 1974-08-02 | Allen & Hanburys Ltd | |
FR2384773A1 (en) * | 1977-03-25 | 1978-10-20 | Allen & Hanburys Ltd | NEW HETEROCYCLIC COMPOUNDS WITH SPASMOLYTIC ACTIVITY |
Also Published As
Publication number | Publication date |
---|---|
FR2160407B1 (en) | 1975-10-17 |
DK138691C (en) | 1979-03-26 |
AU472127B2 (en) | 1976-05-20 |
US3840537A (en) | 1974-10-08 |
DK138691B (en) | 1978-10-16 |
AU4819172A (en) | 1974-05-16 |
ZA727532B (en) | 1973-07-25 |
CH594671A5 (en) | 1978-01-13 |
GB1400999A (en) | 1975-07-16 |
ES408736A1 (en) | 1976-03-01 |
IE37046L (en) | 1973-05-19 |
AT321923B (en) | 1975-04-25 |
IL40686A0 (en) | 1972-12-29 |
DE2255172A1 (en) | 1973-05-24 |
IL40686A (en) | 1975-12-31 |
PH9669A (en) | 1976-02-10 |
SE402915B (en) | 1978-07-24 |
JPS563873B2 (en) | 1981-01-27 |
BE791025A (en) | 1973-05-07 |
CA990292A (en) | 1976-06-01 |
NL7215646A (en) | 1973-05-22 |
JPS4857993A (en) | 1973-08-14 |
IE37046B1 (en) | 1977-04-27 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |